Site-directed mutagenesis and function analysis of glgC gene from Escherichia coli

2008 ◽  
Vol 30 (10) ◽  
pp. 1372-1378
Author(s):  
Shuang ZHOU
2017 ◽  
Vol 49 (12) ◽  
pp. 1099-1111 ◽  
Author(s):  
Yuyu Chen ◽  
Kaimin Lu ◽  
Jianzong Li ◽  
Danfeng Liang ◽  
Hao luo ◽  
...  

2000 ◽  
Vol 275 (3) ◽  
pp. 1897-1901 ◽  
Author(s):  
Chao-Lin Liu ◽  
Chia-Chu Tsai ◽  
Su-Chang Lin ◽  
Li-In Wang ◽  
Chong-Ing Hsu ◽  
...  

1992 ◽  
Vol 267 (32) ◽  
pp. 22830-22836 ◽  
Author(s):  
K Ostanin ◽  
E.H. Harms ◽  
P.E. Stevis ◽  
R Kuciel ◽  
M.M. Zhou ◽  
...  

1994 ◽  
Vol 180 (6) ◽  
pp. 2147-2153 ◽  
Author(s):  
M Pizza ◽  
M R Fontana ◽  
M M Giuliani ◽  
M Domenighini ◽  
C Magagnoli ◽  
...  

Escherichia coli enterotoxin (LT) and the homologous cholera toxin (CT) are A-B toxins that cause travelers' diarrhea and cholera, respectively. So far, experimental live and killed vaccines against these diseases have been developed using only the nontoxic B portion of these toxins. The enzymatically active A subunit has not been used because it is responsible for the toxicity and it is reported to induce a negligible titer of toxin neutralizing antibodies. We used site-directed mutagenesis to inactivate the ADP-ribosyltransferase activity of the A subunit and obtained nontoxic derivatives of LT that elicited a good titer of neutralizing antibodies recognizing the A subunit. These LT mutants and equivalent mutants of CT may be used to improve live and killed vaccines against cholera and enterotoxinogenic E. coli.


Sign in / Sign up

Export Citation Format

Share Document